First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

The latecomer PD-1 inhibitor – already approved for Merkel cell carcinoma – has become the first cancer immunotherapy for ...

Teddi Mellencamp gave an update on her health, including her tumors and her body's response to immunotherapy, during the ...

Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy ...

Research from The University of Western Australia has advanced the development of cancer treatments that enable immune cells ...

Teddi Mellencamp revealed she got another tattoo amid her ongoing battle with cancer and how this ink has a special connection to her dad, John Mellencamp.

A promising new study is changing the way doctors think about treating certain cancers. The research focuses on immunotherapy ...

The reductions in NIH funding and staff are happening at a time when colorectal cancer cases have been rising among younger ...

Leronlimab increased PD-L1 in patients with triple-negative breast cancer, potentially making cold tumors responsive to ...

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

Leading oncologists said AI will one day be as integrated into cancer care as it is in smartphones and self-driving cars. #STATBreakthrough ...